Skip to content
Insider tapeFilings through Fri, Oct 9
Watchlist

Daniel Faga

CEO, President at Anaptysbio, Inc (ANAB)

Purchase track record

Not enough history. Based on 0 purchases with a full 90 days of price history.

—
Avg. 90-day return—
vs. S&P 500—
Beat the market—
Paper profit on buys$0
Total bought / sold$0 / $2.8M

Reported trades

Filed Stock Type Shares Price Value Since
Mar 27SEC ANABAnaptysbio, Inc Sell 510513,134 held (−0%) $56.61 $29K -18.8%
Mar 27SEC ANABAnaptysbio, Inc Sell 2,570510,564 held (−1%) $57.91 $149K -20.7%
Mar 27SEC ANABAnaptysbio, Inc Sell 3,662506,902 held (−1%) $58.62 $215K -21.6%
Mar 27SEC ANABAnaptysbio, Inc Sell 490506,412 held (−0%) $59.62 $29K -22.9%
Mar 27SEC ANABAnaptysbio, Inc Sell 550505,862 held (−0%) $60.63 $33K -24.2%
Mar 27SEC ANABAnaptysbio, Inc Sell 1,012504,850 held (−0%) $62.15 $63K -26.1%
Mar 27SEC ANABAnaptysbio, Inc Sell 2,592502,258 held (−1%) $63.35 $164K -27.5%
Mar 27SEC ANABAnaptysbio, Inc Sell 3,155499,103 held (−1%) $64.19 $203K -28.4%
Mar 27SEC ANABAnaptysbio, Inc Sell 3,038496,065 held (−1%) $65.20 $198K -29.5%
Mar 27SEC ANABAnaptysbio, Inc Sell 100495,965 held (−0%) $65.99 $7K -30.4%
Jan 9SEC ANABAnaptysbio, Inc Sell 14,281479,344 held (−3%) $44.71 $639K +2.8%
Jan 8SEC ANABAnaptysbio, Inc Sell 9,202466,787 held (−2%) $45.11 $415K +1.9%
Jan 6SEC ANABAnaptysbio, Inc Sell 15,309458,139 held (−3%) $43.26 $662K +6.2%